Literature DB >> 22235526

Promoting colorectal cancer screening in public health outreach campaigns.

Tamera R Schneider1, Markus A Feufel, Hans J Berkel.   

Abstract

OBJECTIVE: Research on public outreach campaigns is presented.
BACKGROUND: One study examines the effects of instruction design on adherence to cancer self-screening instructions. A second study examines the effect of persuasive announcements on increasing screening campaign participation.
METHOD: The first study examined adherence to screening (operationalized as returning results for evaluation) given standard instructions, or one of three other versions: persuasive, human factored, or a combination of the two.The second study investigated combining persuasion with a campaign announcement to increase participation (operationalized as picking up a test kit).
RESULTS: The first study found that among first-time participants, the persuasive and human-factored instructions evoked higher result return rates than did the standard. The second study found that participation was significantly increased by adding persuasion to the campaign announcement.
CONCLUSION: Enhancing motivation and reducing cognitive barriers increase adherence to test instructions and increase participation. APPLICATION: These are simple, cost-effective strategies that increase adherence to cancer screening in public outreach campaigns,which may reduce cancer-specific mortality.

Entities:  

Mesh:

Year:  2011        PMID: 22235526     DOI: 10.1177/0018720811427134

Source DB:  PubMed          Journal:  Hum Factors        ISSN: 0018-7208            Impact factor:   2.888


  2 in total

Review 1.  Cancer prevention: state of the art and future prospects.

Authors:  I Valle; D Tramalloni; N L Bragazzi
Journal:  J Prev Med Hyg       Date:  2015-06-10

Review 2.  Heuristics for designing user-centric drug products: Lessons learned from Human Factors and Ergonomics.

Authors:  Markus A Feufel; Gudrun Rauwolf; Felix C Meier; Fatma Karapinar-Çarkit; Maren Heibges
Journal:  Br J Clin Pharmacol       Date:  2020-01-23       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.